Integrated Lung Cancer Screening and Smoking Cessation Program for African American Smokers Aged 50 to 80

What this Trial Is About

African Americans experience the highest rates of lung cancer and related deaths compared to other groups. This research evaluates a multilevel intervention that combines low-dose computed tomography LDCT lung cancer screening with smoking cessation efforts, aiming to reduce health disparities among African American smokers. The study follows NIH strategies addressing health determinants across different life stages to better understand and improve lung cancer prevention in this population. The intervention involves a behavioral program based on the Social Ecological Model targeting individual, institutional, and community levels. Participants are randomly assigned to either receive this multilevel intervention or usual care with no intervention. The study compares the effects of these approaches on tobacco abstinence and lung cancer screening uptake, measuring changes at baseline, immediately after the intervention, and at six months. Participants will be monitored through assessments of smoking behavior, nicotine dependence, and lung cancer screening intent and completion. Key measures include point-prevalence abstinence rates, daily cigarette use, stage of change for quitting smoking, and LDCT screening uptake. These evaluations occur at multiple time points to track progress and outcomes over the study period. The trial aims to provide scalable strategies to improve lung cancer screening and smoking cessation within African American communities.

Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African Americans